Body
Munich, Germany - 28 Aug 2018: The optimal timing of invasive evaluation after a heart attack has been examined in a randomised trial. The late breaking results from the VERDICT trial are presented today in a Hot Line Session at ESC Congress 2018.1
Munich, Germany - 28 Aug 2018: Uric acid reduction with the gout treatment febuxostat reduces adverse events in elderly patients with hyperuricaemia, according to late breaking research presented today in a Hot Line Session at ESC Congress 2018.1
Hyperuricaemia, an abnormally high serum uric acid level, causes gout and is associated with coronary artery disease, hypertension, stroke, renal failure, and death. The FREED study2 examined whether lowering uric acid with febuxostat prevents cerebral, cardiovascular and renal events and death in elderly patients with the condition.
Munich, Germany - 28 Aug 2018: The foods that make up a heart healthy diet for people worldwide may differ from what was previously thought, according to late breaking results from the observational Prospective Urban Rural Epidemiological (PURE) study presented today in a Hot Line Session at ESC Congress 20181 and simultaneously published in the Lancet.
Tokyo, Japan - Researchers from Tokyo Metropolitan University have studied how microswimmers, like bacteria or sperm, swim through fluids with both solid and liquid-like properties e.g. gels. They found that subtle changes in swimmer features, its structure and how it moves, invoke a dramatically different response from the fluid. They also discovered that the similarity in size between the structure of the fluid and the swimmer led to a wide range of interesting behavior.
New York, NY (August 27, 2018)--A phase three clinical trial has shown that a drug called tafamidis significantly reduces deaths and hospitalizations in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive form of heart failure that may be more common than doctors realize.
The findings were published in the New England Journal of Medicine by the trial's co-chair Mathew S. Maurer, MD, a heart failure specialist at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, and colleagues.
The takeaway
Munich, Germany - 27 Aug 2018: Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to standard dual antiplatelet therapy, according to late breaking results from the GLOBAL LEADERS trial presented today in a Hot Line Session at ESC Congress 20181 and published in The Lancet.
Munich, Germany - 26 Aug 2018: The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk, according to late breaking results from the ARRIVE study1 presented today in a Hot Line Session at ESC Congress 20182 and with simultaneous publication in the Lancet.
Munich, Germany - 26 Aug 2018: Body scanners used for security checks are safe for patients with pacemakers and defibrillators, according to late breaking research presented today at ESC Congress 2018.1
Across the globe more than four million patients with heart failure or cardiac arrhythmias rely on pacemakers and defibrillators to keep their hearts beating regularly. It has been unclear whether body scanners used for security checks at airports interfere with the function of cardiac devices.
Munich, Germany - 26 Aug 2018: The ten-year outcomes of the Arterial Revascularisation Trial (ART) are presented today in a Hot Line Session at ESC Congress 2018.1
Munich, Germany - 26 Aug 2018: Fish oil supplements do not prevent heart attacks or strokes in patients with diabetes, according to late breaking results from the ASCEND trial presented today in a Hot Line Session at ESC Congress 20181 and published in the New England Journal of Medicine.
Munich, Germany - UNDER EMBARGO UNTIL 26 Aug 2018: Are wrinkles just an inevitable consequence of ageing, or could they signal something more sinister?
According to research presented in Munich today at the ESC Congress 2018, the annual conference of the European Society of Cardiology (1), people who have lots of deep forehead wrinkles, more than is typical for their age, may have a higher risk of dying of cardiovascular disease (CVD).
Assessing brow wrinkles could be an easy, low-cost way to identify people in a high-risk category for CVD.
Munich, Germany - Aug. 26, 2018: Four out of ten patients with atrial fibrillation but no history of stroke or transient ischaemic attack have previously unknown brain damage, according to the first results of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF) presented today at ESC Congress 2018.1
"Our results suggest that clinically unrecognised brain damage may explain the association between dementia and atrial fibrillation in patients without prior stroke," said Co-Principal Investigator Professor David Conen of McMaster University, Hamilton, Canada.
Munich, Germany - UNDER EMBARGO UNTIL 26 Aug 2018: Patients with high blood pressure are relying solely on medication to reduce their risk of heart attack, stroke and heart failure, rather than decreasing salt intake as instructed by their physicians, according to research presented today at ESC Congress 2018, the annual meeting of the European Society of Cardiology1.
Munich, Germany - Aug. 26, 2018: Middle-aged men who sleep five hours or less per night have twice the risk of developing a major cardiovascular event during the following two decades than men who sleep seven to eight hours, according to research presented today at ESC Congress 2018.1
Study author Ms Moa Bengtsson, of the University of Gothenburg, Sweden, said: "For people with busy lives, sleeping may feel like a waste of time but our study suggests that short sleep could be linked with future cardiovascular disease."
Munich, Germany - Aug. 26, 2018: Researchers have found a sweet spot of six to eight hours sleep a night is most beneficial for heart health. More or less is detrimental. Their findings are presented today at ESC Congress 2018.1
Study author Dr Epameinondas Fountas, of the Onassis Cardiac Surgery Centre, Athens, Greece, said: "We spend one-third of our lives sleeping yet we know little about the impact of this biological need on the cardiovascular system."